1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. AstraZeneca Pharma India Limited
  6. News
  7. Summary
    506820   INE203A01020

ASTRAZENECA PHARMA INDIA LIMITED

(506820)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AstraZeneca Pharma India Limited Approves the Payment of Interim Dividend for the Financial Year 2020-21

08/09/2021 | 09:12am EDT

AstraZeneca Pharma India Limited at its AGM held on August 9, 2021, approved the confirmation of the payment of interim dividend of INR 2 per equity share for the financial year 2020-21.


© S&P Capital IQ 2021
All news about ASTRAZENECA PHARMA INDIA LIMITED
03/21India considers opening COVID boosters to all adults, sources say
RE
02/23ASTRAZENECA PHARMA INDIA : Postal Ballot
PU
02/08AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nin..
CI
02/03Regio Biosciences Enters into License Agreement with Astrazeneca for Phase 2A Asset in ..
CI
02/02Astrazeneca Pharma India Limited Announces Resignation of Kimsuka Narsimhan as Independ..
CI
2021AstraZeneca Pharma India Limited Appoints Shilpa Shridhar Divekar as Additional Directo..
CI
2021AstraZeneca Pharma India's Net Profit Slumps in Fiscal Q2
MT
2021ASTRAZENECA PHARMA INDIA : Gets Import Nod for Selumetinib
MT
2021ASTRAZENECA PHARMA INDIA LIMITED : Ex-dividend day for interim dividend
FA
2021AstraZeneca Pharma India Limited Approves the Payment of Interim Dividend for the Finan..
CI
More news
Financials
Sales 2021 8 136 M 105 M 105 M
Net income 2021 933 M 12,0 M 12,0 M
Net cash 2021 3 402 M 43,7 M 43,7 M
P/E ratio 2021 80,7x
Yield 2021 0,07%
Capitalization 64 415 M 827 M 827 M
EV / Sales 2020 6,90x
EV / Sales 2021 8,83x
Nbr of Employees -
Free-Float 15,3%
Chart ASTRAZENECA PHARMA INDIA LIMITED
Duration : Period :
AstraZeneca Pharma India Limited Technical Analysis Chart | 506820 | INE203A01020 | MarketScreener
Technical analysis trends ASTRAZENECA PHARMA INDIA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Gagandeep Singh Bedi Managing Director & Executive Director
Rajesh Marwaha Chief Financial Officer & Executive Director
Narayan Keelveedhi Seshadri Non-Executive Chairman
Pratap Rudra Secretary, Compliance Officer & Legal Counsel
Revathy Ashok Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PHARMA INDIA LIMITED-19.63%800
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807